Committee for Rational Use of Medicines and Medical DevicesRuxolitinibacute lymphoblastic leukaemiaacute myeloid leukaemiaGvHDGraft-versus-host diseaseaGvHD
…25) including patients authorised to receive ruxolitinib by the Committee for Rational Use of Medicines and Medical Devices.Demographic, clinical (underlying disease, donor type, conditio…